书目名称 | Drug-Induced Lung Injury | 编辑 | Masayuki Hanaoka,Hiroyuki Nakamura,Kazutetsu Aoshi | 视频video | | 概述 | Introduces representative drugs causing the disorder such as antineoplastic drugs, biological products, and molecular target drugs.Will not only benefit respiratory physicians but all medical clinicia | 丛书名称 | Respiratory Disease Series: Diagnostic Tools and Disease Managements | 图书封面 |  | 描述 | This book covers various aspects of a respiratory system disorder associated with prescribed drugs that do not yet have established treatment guidelines, and for which the only treatment is to discontinue taking the drug. Very little clinical evidence regarding the disorder is available, since randomized trials cannot to be carried out, the onset of the disorder cannot be predicted, and the resulting pathological condition is life-threatening. However, the need for an established treatment continues to grow due to the introduction of many new drugs, such as anti-neoplastic drugs, biological products, and molecular target drugs, the adverse effects of which are difficult to differentiate from those of other lung diseases, such as lung infectious diseases. . Drug-Induced Lung Injury offers a highly beneficial resource not only for respiratory physicians but also all medical clinicians who prescribe drugs, nurses, pharmacists and pharmaceutical scientists. Written by pioneering experts in the field, the book examines a wealth of cases and the insights they yield concerning the diagnosis, treatment and specific drugs causing the disease. It not only fosters a deeper understanding of th | 出版日期 | Book 2018 | 关键词 | DLI; Peripheral Blood Test; Molecular Target; Antineoplastic Drug; Antirheumatic Drug; Herbal Medicine; An | 版次 | 1 | doi | https://doi.org/10.1007/978-981-10-4466-3 | isbn_softcover | 978-981-13-5146-4 | isbn_ebook | 978-981-10-4466-3Series ISSN 2509-5552 Series E-ISSN 2509-5560 | issn_series | 2509-5552 | copyright | Springer Nature Singapore Pte Ltd. 2018 |
The information of publication is updating
|
|